Drugs@FDA: FDA Approved Drug Products

Home | Previous Page

Abbreviated New Drug Application (ANDA): 208662
Company: ACP NIMBLE
Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status TE Code RLD RS
TAZAROTENE TAZAROTENE 0.1% CREAM;TOPICAL Prescription AB No No
Original Approvals or Tentative Approvals
Action Date Submission Action Type Submission Classification Review Priority; Orphan Status Letters, Reviews, Labels, Patient Package Insert Notes Url
12/22/2017 ORIG-1 Approval STANDARD

Label is not available on this site.

TAZAROTENE

CREAM;TOPICAL; 0.1%
TE Code = AB

Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status RLD TE Code Application No. Company
AVAGE TAZAROTENE 0.1% CREAM;TOPICAL Prescription Yes AB 021184 ALLERGAN
TAZAROTENE TAZAROTENE 0.1% CREAM;TOPICAL Prescription No AB 208662 ACP NIMBLE
TAZAROTENE TAZAROTENE 0.1% CREAM;TOPICAL Prescription No AB 208258 TARO PHARMS
TAZORAC TAZAROTENE 0.1% CREAM;TOPICAL Prescription Yes AB 021184 ALLERGAN

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English